316 results on '"A. Arlt"'
Search Results
2. Biochemical control with dose reduction in chronic glucocorticoid therapy over 4 years: A phase III extension study of Chronocort (Efmody) in the treatment of Congenital Adrenal Hyperplasia (CAH)
3. Combined [18F]Fluorodeoxyglucose PET and [123I]Iodometomidate-SPECT for diagnostic evaluation of indeterminate adrenal neoplasias - The prospective cross-sectional diagnostic test performance study FAMIAN
4. The differential impact of oral classic and 11-oxygenated androgen precursor administration on downstream androgen metabolism and insulin sensitivity in women with polycystic ovary syndrome
5. Primary unilateral macronodular adrenal hyperplasia with concomitant glucocorticoid and androgen excess and KDM1A inactivation
6. CHAMPAIN study: Initial results from a phase II study of efficacy, safety and tolerability of modified-release hydrocortisones: Chronocort® (Efmody®) versus Plenadren®, in primary adrenal insufficiency
7. Morning cortisol levels in patients with established primary adrenal insufficiency
8. 'Pseudo-failure' of adrenal vein sampling due to cortisol co-secretion by KCNJ5-mutant adenoma, and prediction of complete clinical success by urine hybrid steroid assay
9. Switching patients with Congenital Adrenal Hyperplasia to Modified release hydrocortisone capsules: relative bioavailability and disease control
10. Machine learning-based steroid metabolome analysis reveals three distinct subtypes of polycystic ovary syndrome and implicates 11-oxygenated androgens as major drivers of metabolic risk
11. 'Pseudo-failure' of adrenal vein sampling due to cortisol co-secretion by KCNJ5-mutant adenoma, and prediction of complete clinical success by urine hybrid steroid assay
12. Switching patients with Congenital Adrenal Hyperplasia to Modified release hydrocortisone capsules: relative bioavailability and disease control
13. Machine learning-based steroid metabolome analysis reveals three distinct subtypes of polycystic ovary syndrome and implicates 11-oxygenated androgens as major drivers of metabolic risk
14. Interventions for preventing adrenal crisis - behavioural insights
15. Steroid and global metabolome in benign adrenal tumours with mild autonomous cortisol secretion: analysis by mass spectrometry and machine learning to understand metabolic risk
16. Incidence of COVID-19 in People with Primary Adrenal Insufficiency in the UK and Reported Self-Management - A prospective study
17. Complete clinical cure of primary aldosteronism (PA) is predictable and sustained for at least two years
18. Phaeochromocytomas Most Commonly Present As Adrenal Incidentalomas - A Large Tertiary Centre Experience
19. Simulation via Instant Messaging - Birmingham Advance helps to narrow the gap of knowledge and expectations between clinicians and women with polycystic ovary syndrome: A SIMBA-PCOS mixed-method study
20. Comparison of prednisolone and modified-release hydrocortisone capsules in the treatment of congenital adrenal hyperplasia: dose and disease control
21. Normothermic machine liver perfusion as a tool to study human androgen metabolism
22. Comparison of prednisolone and modified-release hydrocortisone capsules in the treatment of congenital adrenal hyperplasia: dose and disease control
23. Incidence of COVID-19 in People with Primary Adrenal Insufficiency in the UK and Reported Self-Management - A prospective study
24. Complete clinical cure of primary aldosteronism (PA) is predictable and sustained for at least two years
25. Simulation via Instant Messaging - Birmingham Advance helps to narrow the gap of knowledge and expectations between clinicians and women with polycystic ovary syndrome: A SIMBA-PCOS mixed-method study
26. Interventions for preventing adrenal crisis - behavioural insights
27. Phaeochromocytomas Most Commonly Present As Adrenal Incidentalomas - A Large Tertiary Centre Experience
28. Steroid and global metabolome in benign adrenal tumours with mild autonomous cortisol secretion: analysis by mass spectrometry and machine learning to understand metabolic risk
29. Normothermic machine liver perfusion as a tool to study human androgen metabolism
30. Resistance to thyroid hormone alpha: molecular, biochemical and physiological approach to diagnosis and therapy
31. Combining steroid and global metabolome profiling by mass spectrometry with machine learning to investigate metabolic risk in benign adrenal tumours with mild autonomous cortisol secretion
32. Fertility in congenital adrenal hyperplasia (CAH) patients on modified release hydrocortisone capsules (MRHC, Efmody)
33. Improved biochemical control with modified-release hydrocortisone overturns the impaired fludrocortisone effect in salt-wasting CAH patients
34. Simulation via instant messaging − birmingham advance (SIMBA) as a tool to bridge gaps in clinical knowledge and expectations between physicians and patients with polycystic ovary syndrome
35. Blue Morpho: An international survey investigating differences in emotional and psychosexual wellbeing by ethnicity and birthplace in women with polycystic ovary syndrome
36. Altered steroid metabolism in patients following severe trauma: the golden hour study
37. SIMBA for Students: teaching preclinical medical and pharmacy students endocrinology through online simulation - a pilot study
38. Multiplex serum steroid profiling using liquid chromatography mass spectrometry with post column infusion ammonium fluoride
39. The biochemical investigation of PCOS: a UK wide survey of laboratory practice
40. A systematic review and meta-analysis assessing psychosexual wellbeing in people with polycystic ovary syndrome
41. PCOS pearls - findings from the qualitative study assessing the lived experience of people with polycystic ovary syndrome
42. Global impact of PCOS awareness month: challenges and opportunities
43. Perceptions and experiences of women with polycystic ovary syndrome- a systematic review
44. Urinary steroid metabolomics for adrenocortical cancer diagnosis. Comparison of gas chromatography mass spectrometry to liquid chromatography mass spectrometry
45. Modified release hydrocortisone capsules (MRHC, Efmody) improve control of congenital adrenal hyperplasia (CAH) on a lower glucocorticoid dose than standard treatment
46. PCOS SEVa: High prevalence anxiety and body dysmorphia in women with PCOS attending specialist care in the UK and India
47. Fertility in congenital adrenal hyperplasia (CAH) patients on modified release hydrocortisone capsules (MRHC, Efmody)
48. Multiplex serum steroid profiling using liquid chromatography mass spectrometry with post column infusion ammonium fluoride
49. A systematic review and meta-analysis assessing psychosexual wellbeing in people with polycystic ovary syndrome
50. Perceptions and experiences of women with polycystic ovary syndrome- a systematic review
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.